View Older Stories View More Recent Stories

Aug 8, 2025 06:53AM Tempus AI (TEM) Files Mixed Shelf
Aug 8, 2025 06:18AM Tempus AI, Inc (TEM) Tops Q2 EPS by 3c
Aug 8, 2025 06:03AM Tempus AI, Inc (TEM) Reports Q2 Loss of $0.22, provides guidance
Aug 8, 2025 05:29AM Tempus AI (TEM) call put ratio 1.6 calls to 1 put into quarter results
Aug 7, 2025 11:37AM Tempus AI (TEM) call put ratio 2.1 calls to 1 put into quarter results
Aug 7, 2025 05:38AM Tempus AI (TEM) call put ratio 1.8 calls to 1 put quarter results
Jul 18, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 16, 2025 08:00AM Tempus receives FDA clearance for heart condition detection software
Jul 13, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 13, 2025 11:14AM TEM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
Jul 9, 2025 04:00PM Personalis extends Tempus partnership to include colorectal cancer testing
Jul 8, 2025 08:34AM Tempus AI expands care pathway platform to breast cancer
Jul 7, 2025 05:15PM TEM INVESTOR NOTICE: Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 7, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jul 1, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 30, 2025 11:25AM INVESTOR DEADLINE: Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TEM
Jun 30, 2025 07:00AM Tempus AI (TEM) Announces Proposed $400M Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
Jun 25, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 24, 2025 04:05PM INVESTOR ALERT: Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TEM
Jun 19, 2025 04:00PM TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jun 15, 2025 10:36PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 12, 2025 08:33AM Tempus AI (TEM) Announces Collaboration with Northwestern University’s Abrams Research Center on Neurogenomics to Leverage AI for Alzheimer’s Disease Research
Jun 9, 2025 10:56PM ROSEN, A LEADING LAW FIRM, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 8, 2025 10:51PM ROSEN, NATIONALLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 6, 2025 09:05PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 3, 2025 03:57PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Tempus AI, Inc. Investors to Inquire About Securities Class Action Investigation - TEM
Jun 2, 2025 08:47AM TD Cowen Defends Tempus AI Inc (TEM): 'Stock Reaction Looks Overdone'
Jun 2, 2025 08:31AM Tempus AI (TEM) Introduces xM, An Assay to Monitor Immunotherapy Response for Patients with Advanced Cancers
May 28, 2025 09:13AM Tempus AI (TEM) Mentioned as Short at Spruce Point
May 20, 2025 08:33AM Tempus AI (TEM) Announces a Collaboration with Verastem to Develop CDx for First-Ever FDA-Approved KRAS-Mutant Recurrent Low-Grade Serous Ovarian Cancer Combination Treatment
May 14, 2025 08:31AM Tempus AI (TEM) Enters Multi-Year Strategic Collaboration With Boehringer Ingelheim to Advance Its Cancer Pipeline
May 8, 2025 09:24AM Morgan Stanley on Tempus AI Inc (TEM): 'Solid Start to the Year'
May 6, 2025 04:13PM Tempus AI, Inc (TEM) Tops Q1 EPS by 2c
Apr 28, 2025 08:30AM Tempus AI (TEM) Introduces Loop
Apr 23, 2025 08:00AM Tempus AI (TEM) Signs Expanded Strategic Agreements with AstraZeneca and Pathos to Develop the Largest Multimodal Foundation Model in Oncology
Apr 21, 2025 06:05AM BTIG Starts Tempus AI Inc (TEM) at Buy
Apr 15, 2025 09:15AM Illumina (ILMN) and Tempus (TEM) partner to drive the future of precision medicine through genomic AI innovation
Mar 11, 2025 05:16PM Tempus AI (TEM) to acquire Deep 6 AI
Feb 25, 2025 09:09AM Stifel Reiterates Hold Rating on Tempus AI Inc (TEM)
Feb 25, 2025 09:06AM Tempus AI (TEM) Files for 4.84M Share Offering by Selling Stockholders
Feb 25, 2025 05:13AM JPMorgan Downgrades Tempus AI Inc (TEM) to Neutral
Feb 24, 2025 04:50PM After-hours movers: Zoom, Hims & Hers Health, Tempus AI, and more
Feb 24, 2025 04:04PM Tempus AI, Inc (TEM) Reports Q4 Loss of $0.18
Feb 24, 2025 10:46AM Tempus AI (TEM) call put ratio 1.6 calls to 1 put into quarter results and outlook
Feb 24, 2025 05:01AM Tempus AI (TEM) call put ratio 1.4 calls to 1 put into quarter results
Feb 21, 2025 11:00AM Tempus AI (TEM) call put ratio 2.3 calls to 1 put into quarter results
Feb 21, 2025 08:33AM Tempus AI (TEM) and Stemline Therapeutics Collaborate to Implement Tempus Next
Feb 21, 2025 06:21AM Tempus AI (TEM) call put ratio 1.9 calls to 1 put into quarter results
Feb 18, 2025 04:50PM Ares Management (ARES) provides Tempus with total debt package of $560 million
Feb 14, 2025 11:02AM Increasing unusual put option volume: GDDY SMMT FITB AUR TXRH VTRS MNST SATS KC TEM TWLO
View More Recent Stories View Older Stories